Your browser doesn't support javascript.
loading
Lapatinib Inhibits Amphiregulin-induced BeWo Choriocarcinoma Cell Proliferation by Reducing ERK1/2 and AKT Signaling Pathways.
Pires, Leticia Vicosa; Yi, Yuyin; Cheng, Jung-Chien; Pizzolato, Lolita Schneider; Cordero, Elvira; Leung, Peter C K; Brum, Ilma Simoni.
Affiliation
  • Pires LV; Department of Gynaecology and Obstetrics, Porto Alegre Clinical Hospital, Porto Alegre, RS, Brazil.
  • Yi Y; Department of Obstetrics and Gynaecology, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
  • Cheng JC; Department of Obstetrics and Gynaecology, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
  • Pizzolato LS; Department of Obstetrics and Gynaecology, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
  • Cordero E; Department of Physiology, Basic Health Science Institute, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Leung PCK; Department of Physiology, Basic Health Science Institute, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Brum IS; Department of Obstetrics and Gynaecology, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada peter.leung@ubc.ca.
Anticancer Res ; 39(5): 2377-2383, 2019 May.
Article in En | MEDLINE | ID: mdl-31092430

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choriocarcinoma / Receptor, ErbB-2 / Amphiregulin Limits: Female / Humans Language: En Journal: Anticancer Res Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choriocarcinoma / Receptor, ErbB-2 / Amphiregulin Limits: Female / Humans Language: En Journal: Anticancer Res Year: 2019 Document type: Article Affiliation country: